[151 Pages Report] The global Endovenous Laser Therapy Market was valued at US$ 378.3 Million in 2021 and is expected to reach US$ 811.0 Million by 2031, finds `Future Market Insights (FMI) in a recent market survey.
Endovenous Laser Therapy Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2021 | USD 378.3 Million |
| Market Value 2022 | USD 407.6 Million |
| Market Value 2031 | USD 811.0 Million |
| CAGR 2022 to 2031 | 7.9% |
| Key Players | The key players in AngioDynamics, Inc.; Syneron Medical Ltd.; Dornier MedTech GmbH; Alma Lasers Ltd.; Alna-Medical system GmbH; LSO Medical; Wontech Co., Ltd.; intros Medical Laser GmbH and Energist Ltd |
| Share of Top 5 Countries | 59.7% |
The growing prevalence of varicose veins and the availability of user-friendly devices are expected to be primary factors driving the endovenous laser therapy market over the forecast period.
In addition, more and more patients are shifting towards advanced laser therapy from traditional treatment options to avoid unwanted injuries and complications, which is supporting the growth of the endovenous laser therapy market.
Also, the global rise in the rate of obesity is expected to increase the demand for endovenous laser therapy devices, thus driving the global endovenous laser therapy market.
The endovenous laser therapy market holds a 3.8% revenue share of the US$ 10 Billion laser therapy market in 2021. Therefore, the demand for laser systems is on the rise as many patients are adopting minimally invasive procedures such as laser therapy to avoid any further complications.
Moreover, the continuous launch of new and improved products and increasing investment in research and development by the manufacturers of endovenous laser therapy devices would lead to the growth of the global market over the forecast period.
For instance, in April 2021, Alma, unveiled the new Alma PrimeXTM platform today, during a worldwide LIVE launch event, which was broadcasted from its headquarters studio.
Driven by this, sales of endovenous laser therapy are expected to rise at a 7.9% CAGR through 2031.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 7.25% |
| H1, 2022 Projected | 7.83% |
| H1, 2022 Outlook | 7.53% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 30 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (+) 28 ↑ |
The comparative analysis and market growth rate of the global endovenous laser therapy market as studied by Future Market Insights’ will show a negative BPS growth in the H1-2022 outlook as compared to the H1-2022 projected period by 30 BPS.
The market is subject to changes as per macro and industry standards. Factors that affect the market dynamics are related to side effects and postoperative complications. Moreover, the availability of alternative treatments such as traditional vein surgery affects the adoption of endovenous laser therapy. All these factors are responsible for the observed reduction in the BPS values.
However, a positive BPS growth is expected in H1-2022 over H1- 2021 duration with 28 Basis Point Share (BPS). The reasons for the surge in the market is due to high prevalence of varicose veins, the availability of user-friendly featured devices, and the adoption of minimally invasive devices. Additionally, top players are constantly launching new and improved products and increasing funding in research and development to propel market growth.
Sales of endovenous laser therapy grew at a CAGR of 6.7% between 2016 and 2021.
The rapid increase in the number of patients suffering from varicose veins is one of the key factors anticipated to strengthen the demand and growth of the endovenous laser therapy market. Varicose veins are more common in female patients than in male patients. In addition, rising cases of varicose veins because of the growing aging population is a common problem worldwide. Shifting towards an unhealthy lifestyle can as well lead to varicose veins.
Some other factors creating a positive impact on the market are the fast and effective procedures offered by endovenous laser therapy for the treatment of varicose veins over traditional vein surgery. The procedure needs only local anesthesia with minimal discomfort. Also, the therapy has a high success rate. These factors increase the adoption of endovenous laser therapy which in turn leads to market growth.
In addition, the major manufacturers present in the global market are focusing on offering user-friendly equipment to end users for reducing the chances of manual errors. Devices with features such as an intuitive user interface with portable devices & lesser buttons, data storage, and faster procedure setup are being offered by manufacturers to attract a larger customer base. This is anticipated to boost the adoption and demand for the endovenous laser therapy market.
The availability of alternative treatments and the side effects associated with endovenous laser therapy are the major factors anticipated to hamper the growth of the market.
Although endovenous laser therapy is a simple and safe way to treat varicose veins, the possibility of suffering from potential but rare side effects cannot be neglected. The most common side effect of this treatment method is aching and bruising at the puncture site, temporary numbness in the leg, or pain or inflammation in the length of the vein treated which may persist for up to 2 weeks in some patients.
Also, besides endovenous laser therapy, there are many other medical procedures available to treat varicose veins which will restrain the growth of this market. Treatment options such as sclerotherapy, high ligation, and vein stripping are being implemented to treat varicose veins across the globe. Although there are no oral or topical drugs of proven efficacy for venous disease, still many patients rely on drugs for the management and treatment of varicose veins. These options reduce the adoption of endovenous laser therapy thus hindering market growth.
The COVID-19 pandemic was projected to have a major impact on the development of the studied market. The market observed a huge slowdown in its growth due to the spread of the Covid-19 pandemic worldwide. Along with the effects of COVID-19 on public health, there was the subsequent effect of near? universal cancelation and disruption of surgical facilities, which had unprecedented effects on patients with surgical conditions and surgical services.
However, in the post-COVID-19 situation, the increasing cases of varicose veins were expected to drive the market. As recovery began in 2021, key players started to improve their positions through capacity utilization, production expansion, and collaborations with other players in 2021. Also, hospitals and ambulatory surgical centers were focusing on maintaining covid norms in order to prevent infections while performing surgeries.
Principal Consultant
The USA accounted for nearly 90.5% of the North American endovenous laser therapy market in 2021. The growth can be attributed to the increasing number of cases of varicose veins.
For example, as per the American Vein and Lymphatic Society, about 40 million people suffer from varicose veins in 2019, in the USA Also, the increase in the prevalence of obesity and increasing FDA approvals are expected to drive the sales in the USA Furthermore, the technological advancement in laser therapy and favorable reimbursement scenario are some other factors responsible for the growth of the market.
Germany accounted for 19.8% of the Europe endovenous laser therapy market in Europe in 2021. The rising availability of technologically advanced equipment in European countries like Germany is expected to drive the sales of the market during the forecast period.
In Germany, most healthcare treatment is provided under the public health systems, and the government is deliberately providing subsidies for healthcare treatment. This is an additional factor leading to market growth in Germany. Moreover, increasing awareness regarding the treatment of varicose veins is expected to fuel the demand in Germany.
The endovenous laser therapy market in China was worth US$ 18.5 Million in 2021.
The increase in the need for varicose veins treatment in China due to the growing number of people suffering from varicose veins is expected to lead to a rise in the utilization of endovenous laser systems in China, thus resulting in the growth of the market in China. In addition, rapid development in laser technology in the country with an increasing number of local players in China is leading to market development during the forecast period.
Demand for endovenous laser therapy in Japan is expected to rise at an impressive 7.0% CAGR over the forecast period.
The need for early treatment for varicose veins due to the rising geriatric population in Japan is expected to be the primary factor driving the market in the country. Moreover, increasing government initiatives to increase awareness regarding laser therapy is likely to support the growth of the market. An increasing number of product launches in the country will add to the development of the market.
India accounted for 25.3% of the endovenous laser therapy market in Asia Pacific in 2021. The demand for the market in India is due to the rise in the obese population in the country.
Obesity is one of the factors responsible for varicose veins. Unhealthy diet and urbanization of lifestyle lead to obesity. Thus, a rise in the obese population is likely to drive the market in India. In addition, developed infrastructure and increasing disposable income in India are some factors increasing the adoption of laser treatment in the country.
By product, the endovenous laser systems segment held the maximum share of 92.0% in 2021, expanding at a rapid rate during the forecast period. The increase in demand for early treatment due to the rising number of varicose veins cases and the availability of technologically advanced products are primary factors responsible for the growth of the segment over the forecast period.
Moreover, an increase in Research and Development expenditure in several countries is leading to an increase in the number of product launches with advanced features which in turn is increasing the adoption of endovenous laser systems for the treatment of varicose veins. Due to the increasing need for minimally invasive procedures and minimal discomfort from procedures, several patients are adopting laser therapy over traditional treatments, which is adding to segment growth.
By end user, the ambulatory surgical center's segment held the maximum share of 36.2% in 2021, expanding at a rapid rate during the forecast period due to the increasing adoption rate of endovenous laser therapy in ASCs as it is a minimally invasive procedure and is completed in approximately 30-45 minutes.
Furthermore, the continuous innovations in the medical industry are leading to more and more procedures being performed in an outpatient setting rather than in hospitals. In recent years, the number of ambulatory surgical centers has risen due to a rise in demand from the major players in surgical care. physicians, patients, and insurers.
In addition, over 50% of all outpatient surgeries were performed in ASCs (ambulatory surgery centers) in 2017, which is expected to rise by 6-7% as per the Ambulatory Surgery Center Association and ASCA Foundation. This is expected to lead to the development of the segment.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Companies operating in the endovenous laser therapy market are fragmented by nature, with a large number of global and local competitors. These players are involved in a number of strategic alliances. The product launch, FD approval, and acquisition accelerate the manufacturer’s strategy to capitalize on the market share and capture a significant share of the market. Some of the recent instances include:
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2031 |
| Historical Data Available for | 2016 to 2021 |
| Market Analysis | USD Million for Value and Volume in Units |
| Key Countries Covered | The USA, Canada, Germany, The UK, France, Italy, Spain, BENELUX, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa |
| Key Segments Covered | Product, End User, and Region |
| Key Companies Profiled | AngioDynamics, Inc.; Syneron Medical Ltd.; Dornier MedTech GmbH; Alma Lasers Ltd.; Alna-Medical system GmbH; LSO Medical; Wontech Co., Ltd.; intros Medical Laser GmbH; Energist Ltd. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
By Product:
By End User:
By Region:
The global endovenous laser therapy market is projected to reflect high demand in the forecast period with a CAGR of 7.9% owing to the growing caseload for varicose veins and the availability of user-friendly devices.
The sales of endovenous laser therapy in the market have grown at a CAGR of nearly 6.7% between 2016 and 2021. The increasing prevalence of obesity together with the growing geriatric population has boosted the demand for endovenous laser therapy.
North America currently holds the largest market share in endovenous laser therapy. North America held 42.7% of the global market share in the endovenous laser therapy market with the USA being the leading contributor with a market value of over US$ 146.1 Million in 2021.
Endovenous laser therapy in China is likely to hold a share of 35.3% during the forecast period of the East Asian market for endovenous laser therapy. The increase in the need for varicose veins treatment in China due to the growing number of people suffering from varicose veins is expected to lead to rising in the utilization of endovenous laser systems in China, thus resulting in the growth of the market in China.
Availability of novel endovenous laser treatment system, rapid adoption of laser systems by clinics and increased expertise are key trends driving sales of Endovenous laser therapy market across the globe.
India’s endovenous laser therapy market is offering lucrative growth opportunities and is expected to exhibit healthy growth of 8.2% CAGR during the forecast period. Japan's market is expected to exhibit healthy growth of 7.0% CAGR during the forecast period.
The USA, Japan, China, Canada, and Russia are the top 5 countries that are driving the demand for the endovenous laser therapy market.
Leading companies of endovenous laser therapy are AngioDynamics, Inc., Syneron Medical Ltd., Dornier MedTech GmbH, Alma Lasers Ltd., Alna-Medical System GmbH, LSO Medical, Wontech Co., Ltd., intros Medical Laser GmbH and Energist Ltd.
1. Executive Summary | Endovenous Laser Therapy Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Market Context
4.1. Disease Epidemiology
4.2. Product Adoption analysis
4.3. Recent Product Launches and Approval
4.4. Key Regulatory Scenario
4.5. Key Manufacturers Promotional Strategies
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Spending Outlook
5.1.3. Per Capita Healthcare Expenditure Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Growing Caseload for Varicose Veins
5.2.2. Increasing Prevalence of Obesity
5.2.3. New product launches
5.2.4. Regulatory Dynamics
5.2.5. Cost Impact
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID19 perspective and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as Compared to 2008 Economic Analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue By Product
6.4.2. Revenue By End User
6.4.3. Revenue By Region
6.5. 2021 Market Scenario
7. Global Market Demand (in Volume Units) Analysis 2016 to 2021 and Forecast, 2022 to 2031
7.1. Historical Market Volume (Units) Analysis, 2016 to 2021
7.2. Current and Future Market Volume (Units) Projections, 2022 to 2031
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis, By Product
9. Global Market Demand Value (US$ Million) Analysis 2016 to 2021 and Forecast, 2022 to 2031
9.1. Historical Market Value (US$ Million) Analysis, 2016 to 2021
9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2031
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2031, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Value (US$ Million) and Volume (Units) Analysis, By Product, 2016 to 2021
10.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2022 to 2031
10.3.1.1. Endovenous Laser Systems
10.3.1.1.1. Diode Lasers
10.3.1.1.2. YAG Lasers
10.3.1.2. Endovenous laser Fibers
10.3.1.2.1. Bare Tip Laser Fiber
10.3.1.2.2. Radial Tip Laser Fiber
10.3.1.2.3. Gold Tip Laser Fiber
10.4. Market Attractiveness Analysis, By Product
11. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2031, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Value (US$ Million) Analysis, By End User, 2016 to 2021
11.3. Current and Future Market Value (US$ Million) Analysis and Forecast By End User, 2022 to 2031
11.3.1. Hospitals
11.3.2. Ambulatory Surgical Centers
11.3.3. Specialized Clinics
11.4. Market Attractiveness Analysis, By End User
12. Global Market Analysis 2016 to 2021 and Forecast 2022 to 2031, By Region
12.1. Introduction / Key Findings
12.2. Historical Market Value (US$ Million) and Volume (Units) Analysis, By Region, 2016 to 2021
12.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2022 to 2031
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East & Africa (MEA)
12.4. Market Attractiveness Analysis, By Region
13. North America Market Analysis 2016 to 2021 and Forecast 2022 to 2031
13.1. Introduction
13.2. Historical Market Value (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2016 to 2021
13.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2031
13.3.1. By Country
13.3.1.1. The USA
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.5. Drivers and Restraints - Impact Analysis
14. Latin America Market Analysis 2016 to 2021 and Forecast 2022 to 2031
14.1. Introduction
14.2. Historical Market Value (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2016 to 2021
14.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2031
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.5. Drivers and Restraints - Impact Analysis
15. Europe Market Analysis 2016 to 2021 and Forecast 2022 to 2031
15.1. Introduction
15.2. Historical Market Value (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2016 to 2021
15.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2031
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. The UK
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.5. Drivers and Restraints - Impact Analysis
16. South Asia Market Analysis 2016 to 2021 and Forecast 2022 to 2031
16.1. Introduction
16.2. Historical Market Value (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2016 to 2021
16.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2031
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. East Asia Market Analysis 2016 to 2021 and Forecast 2022 to 2031
17.1. Introduction
17.2. Historical Market Value (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2016 to 2021
17.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2031
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.5. Drivers and Restraints - Impact Analysis
18. Oceania Market Analysis 2016 to 2021 and Forecast 2022 to 2031
18.1. Introduction
18.2. Historical Market Value (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2016 to 2021
18.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2031
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By End User
18.4. Market Attractiveness Analysis
18.5. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Market Analysis 2016 to 2021 and Forecast 2022 to 2031
19.1. Introduction
19.2. Historical Market Value (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2016 to 2021
19.3. Current and Future Market Value (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022 to 2031
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkey
19.3.1.3. South Africa
19.3.1.4. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By End User
19.4. Market Attractiveness Analysis
19.5. Drivers and Restraints - Impact Analysis
20. Country Level Market Analysis 2016 to 2021 and Forecast 2022 to 2031
20.1. Introduction
20.1.1. Market Value Proportion Analysis
20.1.2. Global VS. Country Growth Comparison
20.1.3. Pricing Analysis, by Country
20.2. The USA Market Analysis
20.2.1. By Product
20.2.2. By End User
20.3. Canada Market Analysis
20.3.1. By Product
20.3.2. By End User
20.4. Brazil Market Analysis
20.4.1. By Product
20.4.2. By End User
20.5. Mexico Market Analysis
20.5.1. By Product
20.5.2. By End User
20.6. Argentina Market Analysis
20.6.1. By Product
20.6.2. By End User
20.7. The UK Market Analysis
20.7.1. By Product
20.7.2. By End User
20.8. Germany Market Analysis
20.8.1. By Product
20.8.2. By End User
20.9. France Market Analysis
20.9.1. By Product
20.9.2. By End User
20.10. Italy Market Analysis
20.10.1. By Product
20.10.2. By End User
20.11. Spain Market Analysis
20.11.1. By Product
20.11.2. By End User
20.12. Russia Market Analysis
20.12.1. By Product
20.12.2. By End User
20.13. BENELUX Market Analysis
20.13.1. By Product
20.13.2. By End User
20.14. China Market Analysis
20.14.1. By Product
20.14.2. By End User
20.15. Japan Market Analysis
20.15.1. By Product
20.15.2. By End User
20.16. South Korea Market Analysis
20.16.1. By Product
20.16.2. By End User
20.17. India Market Analysis
20.17.1. By Product
20.17.2. By End User
20.18. Thailand Market Analysis
20.18.1. By Product
20.18.2. By End User
20.19. Malaysia Market Analysis
20.19.1. By Product
20.19.2. By End User
20.20. Indonesia Market Analysis
20.20.1. By Product
20.20.2. By End User
20.21. Australia Market Analysis
20.21.1. By Product
20.21.2. By End User
20.22. New Zealand Market Analysis
20.22.1. By Product
20.22.2. By End User
20.23. GCC Countries Market Analysis
20.23.1. By Product
20.23.2. By End User
20.24. South Africa Market Analysis
20.24.1. By Product
20.24.2. By End User
20.25. Turkey Market Analysis
20.25.1. By Product
20.25.2. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Concentration
21.4. Market Presence Analysis
21.4.1. Regional Footprint of Players
21.4.2. Product Footprint of Players
21.4.3. Channel footprint of players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Deep Dive
22.2.1. AngioDynamics, Inc.
22.2.1.1. Overview
22.2.1.2. Product Portfolio
22.2.1.3. Profitability by Market Segments (Product / Channel / Region)
22.2.1.4. Sales Footprint
22.2.1.5. Strategy Overview
22.2.1.5.1. Marketing Strategy
22.2.1.5.2. Product Strategy
22.2.1.5.3. Channel Strategy
22.2.2. Syneron Medical Ltd.
22.2.2.1. Overview
22.2.2.2. Product Portfolio
22.2.2.3. Profitability by Market Segments (Product / Channel / Region)
22.2.2.4. Sales Footprint
22.2.2.5. Strategy Overview
22.2.2.5.1. Marketing Strategy
22.2.2.5.2. Product Strategy
22.2.2.5.3. Channel Strategy
22.2.3. Dornier MedTech GmbH
22.2.3.1. Overview
22.2.3.2. Product Portfolio
22.2.3.3. Profitability by Market Segments (Product / Channel / Region)
22.2.3.4. Sales Footprint
22.2.3.5. Strategy Overview
22.2.3.5.1. Marketing Strategy
22.2.3.5.2. Product Strategy
22.2.3.5.3. Channel Strategy
22.2.4. Alma Lasers Ltd.
22.2.4.1. Overview
22.2.4.2. Product Portfolio
22.2.4.3. Profitability by Market Segments (Product / Channel / Region)
22.2.4.4. Sales Footprint
22.2.4.5. Strategy Overview
22.2.4.5.1. Marketing Strategy
22.2.4.5.2. Product Strategy
22.2.4.5.3. Channel Strategy
22.2.5. Alna-Medical System GmbH
22.2.5.1. Overview
22.2.5.2. Product Portfolio
22.2.5.3. Profitability by Market Segments (Product / Channel / Region)
22.2.5.4. Sales Footprint
22.2.5.5. Strategy Overview
22.2.5.5.1. Marketing Strategy
22.2.5.5.2. Product Strategy
22.2.5.5.3. Channel Strategy
22.2.6. LSO Medical
22.2.6.1. Overview
22.2.6.2. Product Portfolio
22.2.6.3. Profitability by Market Segments (Product / Channel / Region)
22.2.6.4. Sales Footprint
22.2.6.5. Strategy Overview
22.2.6.5.1. Marketing Strategy
22.2.6.5.2. Product Strategy
22.2.6.5.3. Channel Strategy
22.2.7. Wontech Co., Ltd.
22.2.7.1. Overview
22.2.7.2. Product Portfolio
22.2.7.3. Profitability by Market Segments (Product / Channel / Region)
22.2.7.4. Sales Footprint
22.2.7.5. Strategy Overview
22.2.7.5.1. Marketing Strategy
22.2.7.5.2. Product Strategy
22.2.7.5.3. Channel Strategy
22.2.8. intros Medical Laser GmbH
22.2.8.1. Overview
22.2.8.2. Product Portfolio
22.2.8.3. Profitability by Market Segments (Product / Channel / Region)
22.2.8.4. Sales Footprint
22.2.8.5. Strategy Overview
22.2.8.5.1. Marketing Strategy
22.2.8.5.2. Product Strategy
22.2.8.5.3. Channel Strategy
22.2.9. Energist Ltd.
22.2.9.1. Overview
22.2.9.2. Product Portfolio
22.2.9.3. Profitability by Market Segments (Product / Channel / Region)
22.2.9.4. Sales Footprint
22.2.9.5. Strategy Overview
22.2.9.5.1. Marketing Strategy
22.2.9.5.2. Product Strategy
22.2.9.5.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports
Endovenous Laser Therapy Market
